Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Quirion

Showing results (351-360 of 395) with videos related to

Pageof 40
Sort By:
Neuroendocrinology|June 1, 1994
Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonistsA Nicot, A Bérod, D Gully, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell deathM Danik, J G Chabot, C Mercier, et al.
European Journal of Pharmacology|January 29, 1981
The hypotensive effect of centrally administered neurotensin in ratsF Rioux, R Quirion, S St-Pierre, et al.
Behavioural Brain Research|October 8, 2003
Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired ratsW B Rowe, J-P O'Donnell, D Pearson, et al.
Neuroscience|August 1, 1997
Neurotoxic consequences of central long-term administration of interleukin-2 in ratsU K Hanisch, J Neuhaus, W Rowe, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1990
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and peripheryT Dennis, A Fournier, A Cadieux, et al.
Journal of Chemical Neuroanatomy|April 27, 2000
Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization studyY Tong, J G Chabot, S H Shen, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
Neurotransmitter and receptor deficits in senile dementia of the Alzheimer typeR Quirion, J C Martel, Y Robitaille, et al.
Molecular Pharmacology|January 1, 1994
Conformational and biological studies of neuropeptide Y analogs containing structural alterationsA Fournier, D Gagnon, R Quirion, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2000
A novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitisT Esfandyari, W K Macnaughton, R Quirion, et al.
Pageof 40

Showing results (351-360 of 395) with videos related to

Sort By:
Pageof 40
Neuroendocrinology|June 1, 1994
Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonistsA Nicot, A Bérod, D Gully, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991
Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell deathM Danik, J G Chabot, C Mercier, et al.
European Journal of Pharmacology|January 29, 1981
The hypotensive effect of centrally administered neurotensin in ratsF Rioux, R Quirion, S St-Pierre, et al.
Behavioural Brain Research|October 8, 2003
Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired ratsW B Rowe, J-P O'Donnell, D Pearson, et al.
Neuroscience|August 1, 1997
Neurotoxic consequences of central long-term administration of interleukin-2 in ratsU K Hanisch, J Neuhaus, W Rowe, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1990
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and peripheryT Dennis, A Fournier, A Cadieux, et al.
Journal of Chemical Neuroanatomy|April 27, 2000
Ontogenic profile of the expression of the mu opioid receptor gene in the rat telencephalon and diencephalon: an in situ hybridization studyY Tong, J G Chabot, S H Shen, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1986
Neurotransmitter and receptor deficits in senile dementia of the Alzheimer typeR Quirion, J C Martel, Y Robitaille, et al.
Molecular Pharmacology|January 1, 1994
Conformational and biological studies of neuropeptide Y analogs containing structural alterationsA Fournier, D Gagnon, R Quirion, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 6, 2000
A novel receptor for calcitonin gene-related peptide (CGRP) mediates secretion in the rat colon: implications for secretory function in colitisT Esfandyari, W K Macnaughton, R Quirion, et al.
Pageof 40